Pnc Financial Services Group, Inc. Adagio Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $153 Billion
- Q2 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 883 shares of ADGI stock, worth $2,922. This represents 0.0% of its overall portfolio holdings.
Number of Shares
883
Previous 2,248
60.72%
Holding current value
$2,922
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADGI
# of Institutions
66Shares Held
63.1MCall Options Held
13.9KPut Options Held
0-
Mithril Ii Gp LP Austin, TX11.2MShares$37.2 Million27.49% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10.2MShares$33.9 Million0.58% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million39.04% of portfolio
-
Deep Track Capital, LP Greenwich, CT8.59MShares$28.4 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$14.8 Million0.0% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...